<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31619487</article-id>
<article-id pub-id-type="pmc">6794923</article-id>
<article-id pub-id-type="publisher-id">1149-19</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.1149-19.2019</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>0709</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Symposium and Mini-Symposium</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-3298-8001</contrib-id>
<name>
<surname>Lopez Soto</surname>
<given-names>Eduardo Javier</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-5800-5128</contrib-id>
<name>
<surname>Gandal</surname>
<given-names>Michael J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-2669-2570</contrib-id>
<name>
<surname>Gonatopoulos-Pournatzis</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heller</surname>
<given-names>Elizabeth A.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-5499-9559</contrib-id>
<name>
<surname>Luo</surname>
<given-names>Diou</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Sika</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Neuroscience, Brown University, Providence, Rhode Island 02912, </aff>
<aff id="aff2"><sup>2</sup>Department of Psychiatry, Semel Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095, </aff>
<aff id="aff3"><sup>3</sup>Donnelly Centre, University of Toronto, Toronto, Ontario M5S 3E1, Canada, </aff>
<aff id="aff4"><sup>4</sup>Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-5158, </aff>
<aff id="aff5"><sup>5</sup>Department of Biomedical Sciences, Iowa State University, Ames, Iowa 50011, and </aff>
<aff id="aff6"><sup>6</sup>Division of Biomedical Sciences, University of California at Riverside, Riverside, California 92521</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Eduardo Javier Lopez Soto at <email>Eduardo_lopez_soto@brown.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: E.J.L.S. defined the scope of the review, edited the style, wrote abstract, introduction, a specific section, final remarks, and made the schematic Figures; M.J.G., T.G.-P., E.A.H., D.L., and S.Z. (in alphabetical order) wrote the specific sections, and revised and approved the final manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>16</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>16</day>
<month>4</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>39</volume>
<issue>42</issue>
<fpage>8193</fpage>
<lpage>8199</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>9</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2019 the authors</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns04219008193.pdf"></self-uri>
<abstract>
<p>Many cellular and physiological processes are coordinated by regulatory networks that produce a remarkable complexity of transcript isoforms. In the mammalian nervous system, alternative pre-mRNA splicing generates functionally distinct isoforms that play key roles in normal physiology, supporting development, plasticity, complex behaviors, and cognition. Neuronal splicing programs controlled by RNA-binding proteins, are influenced by chromatin modifications and can exhibit neuronal subtype specificity. As highlighted in recent publications, aberrant alternative splicing is a major contributor to disease phenotypes. Therefore, understanding the underlying mechanisms of alternative splicing regulation and identifying functional splicing isoforms with critical phenotypic roles are expected to provide a comprehensive resource for therapeutic development, as illuminated by recent successful interventions of spinal muscular atrophy. Here, we discuss the latest progress in the study of the emerging complexity of alternative splicing mechanisms in neurons, and how these findings inform new therapies to correct and control splicing defects.</p>
</abstract>
<kwd-group>
<kwd>alternative splicing</kwd>
<kwd>CACNA1B</kwd>
<kwd>spinal muscular atrophy (SMA)</kwd>
<kwd>autism spectrum disorder (ASD)</kwd>
<kwd>axonogenesis</kwd>
<kwd>chromatin</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>